Fair value (multi-method)
Four independent methods triangulate what GILD is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$574,621.16
Method range
$26.33 – $574,621.16
median $159.56
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $574,621.16 | +444,790.96% |
| Exit multiple | — | — |
| Analyst target | $159.56 | +23.54% |
| Graham number | $26.33 | -79.62% |
- Forward DCF$574,621.16
- Exit multiple—
- Analyst target$159.56
- Graham number$26.33
Stock price
$129.16
FCF / share (TTM)
$1.95
3Y FCF CAGR
-3.1%
Fair value @ hist. growth
$33.70
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
13.1%
per year over your projection horizon
Margin of safety -283.3% vs hist-growth DCF
Historical 3Y CAGR
-3.1%
Your model implies
13.1%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -3% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 11.3% | 9.8% | 8.0% | 5.8% | 3.0% |
| 5.2% | 12.1% | 10.7% | 9.0% | 7.0% | 4.4% |
| 6.2% | 15.5% | 14.3% | 13.1% | 11.6% | 9.9% |
| 7.2% | 18.4% | 17.5% | 16.5% | 15.3% | 14.0% |
| 8.2% | 21.1% | 20.3% | 19.4% | 18.5% | 17.5% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$17.0B
Total debt − cash
Beta
0.33
Vs market benchmark
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation